Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (381-390 of 546) with videos related to

Pageof 55
Sort By:
Frontiers in Neurology|January 10, 2018
<i>In Vivo</i> Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [<sup>18</sup>F]GE180-PET StudyAndreas Zwergal, Lisa Günther, Matthias Brendel, et al.
Annals of Hematology|October 20, 2023
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
EJNMMI Research|November 19, 2017
TSPO imaging using the novel PET ligand [<sup>18</sup>F]GE-180: quantification approaches in patients with multiple sclerosisLena Vomacka, Nathalie Lisa Albert, Simon Lindner, et al.
Frontiers in Oncology|May 17, 2021
TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic <sup>18</sup>F-FET PET?Marcus Unterrainer, Viktoria Ruf, Katharina von Rohr, et al.
Cytotherapy|April 13, 2023
Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Neuro-Oncology|October 24, 2012
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomasNathalie L Jansen, Christoph Schwartz, Vera Graute, et al.
Neuroimage|December 13, 2005
High opiate receptor binding potential in the human lateral pain systemUlf Baumgärtner, Hans-Georg Buchholz, Alexander Bellosevich, et al.
Frontiers in Oncology|April 16, 2021
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET ImagingAdrien Holzgreve, Annamaria Biczok, Viktoria C Ruf, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 18, 2020
Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel <sup>68</sup>Ga-mCXCL12 PET tracerMathias Johannes Zacherl, Andrei Todica, Carmen Wängler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2014
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patientsNathalie L Jansen, Bogdana Suchorska, Vera Wenter, et al.
Pageof 55

Showing results (381-390 of 546) with videos related to

Sort By:
Pageof 55
Frontiers in Neurology|January 10, 2018
<i>In Vivo</i> Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [<sup>18</sup>F]GE180-PET StudyAndreas Zwergal, Lisa Günther, Matthias Brendel, et al.
Annals of Hematology|October 20, 2023
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
EJNMMI Research|November 19, 2017
TSPO imaging using the novel PET ligand [<sup>18</sup>F]GE-180: quantification approaches in patients with multiple sclerosisLena Vomacka, Nathalie Lisa Albert, Simon Lindner, et al.
Frontiers in Oncology|May 17, 2021
TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic <sup>18</sup>F-FET PET?Marcus Unterrainer, Viktoria Ruf, Katharina von Rohr, et al.
Cytotherapy|April 13, 2023
Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Neuro-Oncology|October 24, 2012
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomasNathalie L Jansen, Christoph Schwartz, Vera Graute, et al.
Neuroimage|December 13, 2005
High opiate receptor binding potential in the human lateral pain systemUlf Baumgärtner, Hans-Georg Buchholz, Alexander Bellosevich, et al.
Frontiers in Oncology|April 16, 2021
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET ImagingAdrien Holzgreve, Annamaria Biczok, Viktoria C Ruf, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 18, 2020
Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel <sup>68</sup>Ga-mCXCL12 PET tracerMathias Johannes Zacherl, Andrei Todica, Carmen Wängler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2014
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patientsNathalie L Jansen, Bogdana Suchorska, Vera Wenter, et al.
Pageof 55